Echo award win caps period of strong, prolonged growth for dki direct

ECHO Award Win Caps Period of Strong,
Prolonged Growth for DKI Direct
Agency Wins Fourth Coveted Award in One Year
Montvale, NJ, October 16, 2005 – DKI Direct (www.dkidirect.com), a leading Patient
Relationship Marketing (PRM) agency, has won a coveted ECHO Award for their EndoKnow
program, which educates women on chronic pelvic pain, endometriosis and available treatment
options, specifically TAP Pharmaceutical Products, Inc.'s product Lupron Depot®.
The award will be presented at the Direct Marketing Association's (DMA) Conference in Atlanta,October 16—19, 2005. Winning campaigns will be on display and keynote speakers will includeStephen Wynn, former Chairman and CEO of Mirage Resorts, Inc.
ECHO Award winners are selected because their programs offer brilliant strategy, breakthroughcreative and phenomenal results. The excellence of DKI's programming strongly justifies theirreceipt of an esteemed ECHO award.
The EndoKnow program promises women away to "Outsmart the Pain,” validating the factthat endometriosis is a serious diseaserequiring strong medicine. EndoKnow offersendometriosis sufferers the knowledge theyneed to make real, liberating choices in theirlives and offers education about the disease, itssymptoms and treatment options.
"The EndoKnow Program was launched inOctober 2003 and it continues to generategreat results," states Koren. "It is a stellar,groundbreaking program whose success is duein large part to the tailored consumerexperience. Our years of experience allow us tostudy the behaviors of the patient targets andcustomize the educational messages andofferings." DKI's approach to patient relationship marketing is unique in the pharmaceutical industry: awinning combination of direct response, interactive technology and years of direct-to-patientmarketing experience. DKI works closely with clients to put strategies and ROI projections downon paper, and then rigorously monitors the results.
Presently working with nine different brands, DKI's staff has doubled in a year. By year's end, DKIwill have launched five patient education programs in the oncology arena alone.
Recent business wins for DKI include two exceptional PRM programs: DKI was recently selected by Genentech to do a pre-launch program for a new drug to buildawareness of the category prior to launch while building a valuable patient database primedfor supporting branded messages post launch, andDKI just launched their first international patient relationship marketing program for AbbottInternational's Humira in Germany. This is a breakthrough since patient marketing isvirtually nonexistent in Europe, where the guidelines are much more stringent than in theUnited States.
This ECHO award joins other coveted honors that testify to DKI’s talents, including: The 2005 eHealthcare Leadership Award for www.pcare.infoThe 2005 WWW Health Award of Merit for Patient Education (see www.asthmamatters.com)The 2004 Creative Summit Award (Silver) for EndoKnowThe 2003 WWW Health Award of Merit for Patient Education (see www.kytril.com)The 2003 WWW Health Award of Merit for Patient Education (see www.soriatane.com)The 2002 eHealthcare Leadership Platinum Award for Best Health/Healthcare Content, (seewww.kytril.com)The 2002 AAD Gold Triangle Award for Psoria-Sense Patient Education ProgramThe 2002 Bronze Award for Patient Education, (see www.kytril.com) More Information on DKI Direct
DKI Direct is convinced that the skill of a physician and the will of a patient create a powerfulcombination. For this reason, their strategies are developed to act as catalysts to match those inneed with those who can help them. DKI achieves this through a rigorous audit of consumerinsights that identifies unmet patient needs, preferred channels and patient value. They thenleverage a three-dimensional segmentation plan based on the patient profiles that emerge tooptimize product marketing. With this core construct in place, DKI Direct crafts a patientcommunications plan that leverages key moments in the patient lifecycle with opportunities toincrease patient commitment and brand preference, motivating action that can be measuredthrough ROI calculations.
DKI knows from experience that comprehensive information architecture strategies are absoluterequirements for building a goal-oriented, user-friendly communication experience. DKI deliversfully thought-out information architecture that guarantees a program's content is clear andintuitive, transforming patient messages into powerful visual narratives that help guide consumerstoward desired actions.
Please contact Daniella Koren at 201-391-6000 or visit www.dkidirect.com.

Source: https://www.dkidirect.com/wp-content/themes/dkidirect/pdf/echo_award_announcement.pdf

Volume 7-6

Krill Oil Original Research Evaluation of the Effects of Neptune Krill Oil on the Clinical Course of Hyperlipidemia Ruxandra Bunea, MD; Khassan El Farrah, MD, MSc; Luisa Deutsch, MD Abstract results of the present study demonstrate within OBJECTIVE: To assess the effects of krill oil high levels of confidence that krill oil is effective on blood lipids, specifically

Ewcm 400 family a4 5-04

EWCM 400 (412-415-418) cod. 9IS43018 compressor pack controllers rel. 4/04 • “Copy Card” (fast parameters program- PROGRAMMING PARAMETERS see Table of Parameters For further information, see the technical GENERAL DESCRIPTION TECHNICAL DATA The “EWCM 400 family” is a series of low-cost controllers specially designed for the USER INTERFACE control of the machine

© 2008-2018 Medical News